CN Patent

CN111170911A — 用于治疗细菌感染性疾病的截短侧耳素类化合物

Assigned to Antikang Wuxi Biotechnology Co ltd · Expires 2020-05-19 · 6y expired

What this patent protects

本发明涉及新型截短侧耳素类化合物、它们的药物组合物及使用方法。此外，本发明还涉及用于治疗细菌感染的治疗方法，包括耐药性微生物造成的感染，包括多重耐药性微生物。

USPTO Abstract

本发明涉及新型截短侧耳素类化合物、它们的药物组合物及使用方法。此外，本发明还涉及用于治疗细菌感染的治疗方法，包括耐药性微生物造成的感染，包括多重耐药性微生物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111170911A
Jurisdiction
CN
Classification
—
Expires
2020-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Antikang Wuxi Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.